Cancer patients should have access to device to treat fluid retention at home, says NICEBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2272 (Published 22 March 2012) Cite this as: BMJ 2012;344:e2272
- Zosia Kmietowicz
Patients with cancer who have recurrent malignant ascites should have the option of treating themselves at home, says new guidance from the National Institute for Health and Clinical Excellence.
The institute’s Medical Technology Advisory Committee says that the PleurX peritoneal catheter drainage system should be used for patients who need vacuum assisted drainage for recurrent malignant ascites and whose treatment for cancer is unlikely to resolve the problem. The guidance applies to England.
This is the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial